Validation of functional imaging with pathology for tumor delineation in the prostate

Radiotherapy and Oncology

Volumn 94, Issue 2, 2010, Pages 145-150

  Groenendaal, Greetje ^a   Moman, Maaike R ^a   Korporaal, Johannes G ^a   van Diest, Paul J ^a   van Vulpen, Marco ^a   Philippens, Marielle E P ^a   van der Heide, Uulke A ^a  

^a UNIVERSITY MEDICAL CENTER UTRECHT   (Netherlands)

Author keywords

Diffusion weighted imaging; Dynamic contrast enhanced MRI; Pathology; Prostate; Tumor delineation

Indexed keywords

EOSIN; HEMATOXYLIN;

ADULT; AGED; ARTICLE; CLINICAL ARTICLE; CONTRAST ENHANCEMENT; CONTROLLED STUDY; DIAGNOSTIC ACCURACY; DIFFUSION WEIGHTED IMAGING; ERROR; FUNCTIONAL MAGNETIC RESONANCE IMAGING; HUMAN; MALE; PATHOLOGY; PRIORITY JOURNAL; PROSTATE BIOPSY; PROSTATE CANCER; PROSTATECTOMY; REGISTRATION; STAINING; VALIDATION STUDY;

AGED; BIOPSY; CONTRAST MEDIA; DIFFUSION MAGNETIC RESONANCE IMAGING; HUMANS; IMAGE INTERPRETATION, COMPUTER-ASSISTED; IMAGING, THREE-DIMENSIONAL; MAGNETIC RESONANCE IMAGING; MALE; MIDDLE AGED; ORGANOMETALLIC COMPOUNDS; PROSTATECTOMY; PROSTATIC NEOPLASMS; STAINING AND LABELING;

EID: 77249175269     PISSN: 01678140     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.radonc.2009.12.034     Document Type: Article

References (34)

1. Peeters S.T.H., Heemsbergen W.D., Koper P.C.M., et al. Dose-response in radiotherapy for localized prostate cancer: results of the Dutch multicenter randomized phase III trial comparing 68 Gy of radiotherapy with 78 Gy. J Clin Oncol 24 (2006) 1990-1996
2. Pollack A., Zagars G.K., Starkschall G., et al. Prostate cancer radiation dose response: results of the M.D. Anderson phase III randomized trial. Int J Radiat Oncol Biol Phys 53 (2002) 1097-1105
3. Zietman A.L., DeSilvio M.L., Slater J.D., et al. Comparison of conventional-dose vs high-dose conformal radiation therapy in clinically localized adenocarcinoma of the prostate: a randomized controlled trial. JAMA 294 (2005) 1233-1239
4. Al-Mamgani A., Van Putten W.L.J., Heemsbergen W.D., et al. Update of dutch multicenter dose-escalation trial of radiotherapy for localized prostate cancer. Int J Radiat Oncol Biol Phys 72 (2008) 980-988
5. Cellini N., Morganti A.G., Mattiucci G.C., et al. Analysis of intraprostatic failures in patients treated with hormonal therapy and radiotherapy: implications for conformal therapy planning. Int J Radiat Oncol Biol Phys 53 (2002) 595-599
6. Pucar D., Hricak H., Shukla-Dave A., et al. Clinically significant prostate cancer local recurrence after radiation therapy occurs at the site of primary tumor: magnetic resonance imaging and step-section pathology evidence. Int J Radiat Oncol Biol Phys 69 (2007) 62-69
7. Pickett B., Vigneault E., Kurhanewicz J., Verhey L., and Roach M. Static field intensity modulation to treat a dominant intra-prostatic lesion to 90 Gy compared to seven field three-dimensional radiotherapy. Int J Radiat Oncol Biol Phys 43 (1999) 921-929
8. Van Lin E.N.J.T., Fütterer J.J., Heijmink S.W.T.P.J., et al. IMRT boost dose planning on dominant intraprostatic lesions: gold marker-based three-dimensional fusion of CT with dynamic contrast-enhanced and 1H-spectroscopic MRI. Int J Radiat Oncol Biol Phys 65 (2006) 291-303
9. Singh A.K., Guion P., Sears-Crouse N., et al. Simultaneous integrated boost of biopsy proven, MRI defined dominant intra-prostatic lesions to 95 Gray with IMRT: early results of a phase I NCI study. Radiat Oncol 2 (2007) 36
10. Pickles M.D., Gibbs P., Sreenivas M., and Turnbull L.W. Diffusion-weighted imaging of normal and malignant prostate tissue at 3.0 T. J Magn Reson Imaging 23 (2006) 130-134
11. Gibbs P., Pickles M.D., and Turnbull L.W. Diffusion imaging of the prostate at 3.0 T. Invest Radiol 41 (2006) 185-188
12. Kumar V., Jagannathan N.R., Kumar R., et al. Apparent diffusion coefficient of the prostate in men prior to biopsy: determination of a cut-off value to predict malignancy of the peripheral zone. NMR Biomed 20 (2007) 505-511
13. Van Dorsten F.A., van der Graaf M., Engelbrecht M.R.W., et al. Combined quantitative dynamic contrast-enhanced MR imaging an 1H MR spectroscopic imaging of human prostate cancer. J Magn Reson Imaging 20 (2004) 279-287
14. Franiel T., Lüdemann L., Rudolph B., et al. Evaluation of normal prostate tissue, chronic prostatitis, and prostate cancer by quantitative perfusion analysis using a dynamic contrast-enhanced inversion-prepared dual-contrast gradient echo sequence. Invest Radiol 43 (2008) 481-487
15. Kozlowski P., Chang S.D., Jones E.C., Berean K.W., Chen H., and Goldenberg S.L. Combined diffusion-weighted and dynamic contrast-enhanced MRI for prostate cancer diagnosis - correlation with biopsy and histopathology. J Magn Reson Imaging 24 (2006) 108-113
16. Ocak I., Bernardo M., Metzger G., et al. Dynamic contrast-enhanced MRI of prostate cancer at 3 T: a study of pharmacokinetic parameters. Am J Roentgenol 189 (2007) 849
17. Scheidler J., Hricak H., Vigneron D.B., et al. Prostate cancer: localization with three-dimensional proton MR spectroscopic imaging - clinicopathologic study. Radiology 213 (1999) 473-480
18. Fütterer J.J., Heijmink S.W.T.P.J., Scheenen T.W.J., et al. Prostate cancer localization with dynamic contrast-enhanced MR imaging and proton MR spectroscopic imaging. Radiology 241 (2006) 449-458
19. Hosseinzadeh K., and Schwarz S.D. Endorectal diffusion-weighted imaging in prostate cancer to differentiate malignant and benign peripheral zone tissue. J Magn Reson Imaging 20 (2004) 654-661
20. Sato C., Naganawa S., Nakamura T., et al. Differentiation of noncancerous tissue and cancer lesions by apparent diffusion coefficient values in transition and peripheral zones of the prostate. J Magn Reson Imaging 21 (2005) 258-262
21. Miao H., Fukatsu H., and Ishigaki T. Prostate cancer detection with 3-T MRI: comparison of diffusion-weighted and T2-weighted imaging. Eur J Radiol 61 (2007) 297-302
22. Haider M.A., van der Kwast T.H., Tanguay J., et al. Combined T2-weighted and diffusion-weighted MRI for localization of prostate cancer. Am J Roentgenol 189 (2007) 323-328
23. van Vulpen M., van den Berg C.A.T., Moman M.R., and van der Heide U.A. Difficulties and potential of correlating local recurrences in prostate cancer with the delivered local dose. Radiother Oncol 93 (2009) 180-184
24. Franiel T., Lüdemann L., Taupitz M., Bömer D., and Beyersdorff D.D. MRI before and after external beam intensity-modulated radiotherapy of patients with prostate cancer: the feasibility of monitoring of radiation-induced tissue changes using a dynamic contrast-enhanced inversion-prepared dual-contrast gradient echo sequence. Radiother Oncol 93 (2009) 241-245
25. Kershaw L.E., Logue J.P., Hutchinson C.E., Clarke N.W., and Buckley D.L. Late tissue effects following radiotherapy and neoadjuvant hormone therapy of the prostate measured with quantitative magnetic resonance imaging. Radiother Oncol 88 (2008) 127-134
26. Park H., Piert M.R., Khan A., et al. Registration methodology for histological sections and in vivo imaging of human prostate. Acta Radiol 15 (2008) 1027-1039
27. Tofts P.S., Brix G., Buckley D.L., et al. Estimating kinetic parameters from dynamic contrast-enhanced T1-weighted MRI of a diffusable tracer: standardized quantities and symbols. J Magn Reson Imaging 10 (1999) 223-232
28. Murase K. Efficient method for calculating kinetic parameters using T1-weighted dynamic contrast-enhanced magnetic resonance imaging. Magn Reson Med 51 (2004) 858-862
29. Klein S., Staring M., Murphy K., Viergever M.A., and Pluim J.P.W. Elastix: a toolbox for intensity-based medical image registration. IEEE Trans Med Imaging 29 (2010) 196-205
30. Van der Put R.W., Raaymakers B.W., Kerkhof E.M., Van Vulpen M., and Lagendijk J.J.W. A novel method for comparing 3D target volume delineations in radiotherapy. Phys Med Biol 53 (2008) 2149-2159
31. Langer D.L., Van der Kwast T.H., Evans A.J., et al. Intermixed normal tissue within prostate cancer: effect on MR imaging measurements of apparent diffusion coefficient and T2 - sparse versus dense cancers. Radiology 249 (2008) 900-908
32. Klein S., van der Heide U.A., Lips I.M., van Vulpen M., Staring M., and Pluim J.P.W. Automatic segmentation of the prostate in 3D MR images by atlas matching using localized mutual information. Med Phys 35 (2008) 1407-1417
33. Van der Heide U.A., Kotte A.N.T.J., Dehnad H., Hofman P., Lagendijk J.J.W., and Van Vulpen M. Analysis of fiducial marker-based position verification in the external beam radiotherapy of patients with prostate cancer. Radiother Oncol 82 (2007) 38-45
34. Goitein M., and Niemierko A. Intensity modulated therapy and inhomogeneous dose to the tumor: a note of caution. Int J Radiat Oncol Biol Phys 36 (1996) 519-522